Patents by Inventor Qianyong Liu

Qianyong Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-PD-L1 diabodies and the use thereof
    Patent number: 12263234
    Abstract: Provided are anti-PD-L1 diabodies, imaging agents, methods and kits for determination of the distribution and expression levels of PD-L1 in an individual having a disease or condition. Anti-PD-L1 diabody agents, and methods for treating diseases or disorders are also provided.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: April 1, 2025
    Assignee: Tayu Huaxia Biotech Medical Group Co., Ltd.
    Inventors: Lieping Chen, Zhenguo Wen, Liqun Luo, Qianyong Liu
  • Compositions and methods for imaging
    Patent number: 12144875
    Abstract: Provided are methods, imaging agents and kits for determination of the distribution and expression levels of an immune checkpoint ligand (such as PD-L1 or a PD-L1 like ligand) in an individual having a disease or condition. Anti-PD-L1 antibody agents are also provided.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: November 19, 2024
    Assignee: Tayu Huaxia Biotech Medical Group Co., Ltd.
    Inventors: Lieping Chen, Liqun Luo, Zhenguo Wen, Qianyong Liu
  • ANTI-PD-L1 DIABODIES AND THE USE THEREOF
    Publication number: 20220088232
    Abstract: Provided are anti-PD-L1 diabodies, imaging agents, methods and kits for determination of the distribution and expression levels of PD-L1 in an individual having a disease or condition. Anti-PD-L1 diabody agents, and methods for treating diseases or disorders are also provided.
    Type: Application
    Filed: January 17, 2020
    Publication date: March 24, 2022
    Applicant: Tayu Huaxia Biotech Medical Group Co., Ltd.
    Inventors: Lieping CHEN, Zhenguo WEN, Liqun LUO, Qianyong LIU
  • COMPOSITIONS AND METHODS FOR IMAGING
    Publication number: 20210309745
    Abstract: The present application provides methods, imaging agents and kits for determination of the distribution and expression levels of an immune checkpoint ligand (such as PD-L1 or a PD-L1 like ligand) in an individual having a disease or condition. Anti-PD-L1 antibody agents are also provided.
    Type: Application
    Filed: July 26, 2018
    Publication date: October 7, 2021
    Applicant: Tayu Huaxia Biotech Medical Group Co., Ltd.
    Inventors: Lieping CHEN, Liqun LUO, Zhenguo WEN, Qianyong LIU
  • COMPOSITIONS AND METHODS FOR IMAGING
    Publication number: 20210213145
    Abstract: Provided are methods, imaging agents and kits for determination of the distribution and expression levels of an immune checkpoint ligand (such as PD-L1 or a PD-L1 like ligand) in an individual having a disease or condition. Anti-PD-L1 antibody agents are also provided.
    Type: Application
    Filed: May 31, 2019
    Publication date: July 15, 2021
    Applicant: Tayu Huaxia Biotech Medical Group Co., Ltd.
    Inventors: Lieping CHEN, Liqun LUO, Zhenguo WEN, Qianyong LIU
  • PROSTACYCLIN RECEPTOR AGONISTS FOR REDUCTION OF BODY FAT
    Publication number: 20200171026
    Abstract: Prostacyclin (PGI2) analogues which are agonists of the prostacyclin receptor (PI) are demonstrated to activate lipolytic activity in adipocytes. Also described are pharmaceutical compositions and methods for using the PGI2 receptor agonists to reduce subcutaneous adipose tissue and to treat or reduce symptoms of obesity-related diseases or disorders such as diabetes mellitus, fatty liver disease and cardiovascular disease.
    Type: Application
    Filed: July 27, 2018
    Publication date: June 4, 2020
    Inventors: Yong-Xin Li, Neil J. Poloso, John E. Donello, Qianyong Liu